Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy.
Kawaguchi Y, Saito B, Nakata A, Matsui T, Sasaki Y, Shimada S, Abe M, Watanuki M, Baba Y, Murai S, Arai N, Fujiwara S, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Hattori N, Harada H, Nakamaki T.
Kawaguchi Y, et al. Among authors: saito b.
Int J Hematol. 2020 Sep;112(3):341-348. doi: 10.1007/s12185-020-02910-0. Epub 2020 Jun 10.
Int J Hematol. 2020.
PMID: 32524308